HealthEquity (HQY), a leader in health savings and financial services, has experienced a diverse journey in the stock market since its introduction. The following table highlights the annual performance of HealthEquity’s stock, demonstrating a path marked by significant growth and occasional setbacks. This overview captures the company’s ability to navigate market fluctuations, showcasing its dedication to enhancing healthcare savings and investment solutions for individuals and employers alike.
Annual Returns of HealthEquity Stock (HQY)
| Year | Beginning | Ending | Gain/Loss | S&P 500 |
|---|---|---|---|---|
| 2023 | $60.70 | $66.30 | 9.23% | 24.73% |
| 2022 | $46.84 | $61.64 | 31.60% | -19.95% |
| 2021 | $68.91 | $44.24 | -35.80% | 28.79% |
| 2020 | $72.25 | $69.71 | -3.52% | 15.29% |
| 2019 | $59.11 | $74.07 | 25.31% | 28.71% |
| 2018 | $46.47 | $59.65 | 28.36% | -7.01% |
| 2017 | $40.19 | $46.66 | 16.10% | 18.42% |
| 2016 | $24.97 | $40.52 | 62.27% | 11.24% |
| 2015 | $24.70 | $25.07 | 1.50% | -0.69% |
| 2014 | $17.60 | $25.45 | 44.60% | 12.39% |
The table above displays the HQY Yearly Return Rate, highlighting HealthEquity’s annual stock performance on a split-adjusted basis. This data does not include dividends, stock spin-offs, taxes, or transaction commissions.
HealthEquity (HQY) Stock History
The Early Years: 2014-2015
HealthEquity (HQY) embarked on its public market journey with an impressive start. In 2014, the company’s stock price rose from $17.60 to $25.45, marking a substantial gain of 44.60%. This initial success showcased the market’s strong confidence in HealthEquity’s potential.
The following year, 2015, saw a more modest increase, with the stock price inching up from $24.70 to $25.07, a gain of 1.50%. Despite the slower growth, HealthEquity demonstrated stability in a fluctuating market environment.
Growth and Momentum: 2016-2017
In 2016, HealthEquity witnessed a remarkable surge, with its stock price soaring from $24.97 to $40.52, reflecting a significant gain of 62.27%. This period highlighted the company’s rapid expansion and its increasing importance in the healthcare sector.
The momentum continued into 2017, with the stock price moving from $40.19 to $46.66, achieving a gain of 16.10%. These two years marked a period of strong performance and growth for HealthEquity, further establishing its foothold in the market.
Fluctuations and Recovery: 2018-2019
During 2018, HealthEquity’s stock continued to perform well, increasing from $46.47 to $59.65, a gain of 28.36%, indicating robust growth and market positioning.
In 2019, the company saw even further growth, with the stock price moving up to $74.07, a gain of 25.31%. This consistent performance demonstrated HealthEquity’s ability to grow and thrive, even as it began to face more competition and market pressures.
Challenges and Resilience: 2020-2021
The years 2020 and 2021 presented new challenges. In 2020, HealthEquity’s stock experienced a slight decline, with the price dropping from $72.25 to $69.71, a -3.52% change. The following year, 2021, was more challenging, as the stock price plummeted from $68.91 to $44.24, marking a significant loss of -35.80%. These years tested HealthEquity’s resilience amidst market turbulence and broader economic uncertainties.
Recovery and Growth: 2022-2023
Emerging from the previous years’ challenges, HealthEquity began a phase of recovery and growth in 2022. The stock price rebounded from $46.84 to $61.64, reflecting a robust gain of 31.60%. This turnaround was a clear indicator of the company’s strong fundamentals and its adaptive strategies.
In 2023, the upward trend continued, with the stock price moving from $60.70 to $66.30, a gain of 9.23%. This period underscored HealthEquity’s ability to navigate through market volatilities and continue its growth trajectory.